Blog

Aaron Goodman/X

Oct 6, 2024, 12:18

Aaron Goodman: CMV drugs!

Aaron Goodman posted the following on X:

“CMV drugs!

Ganciclovir
GCV-phos -> DNA
WBC

Foscarnet
Mimic of pyrophosphate interferes with exchange in DNA
Nephrotoxicity, electrolytes

Cidofovir CDV-phos -> DNA
Nephrotoxicity/Fanconi syndrome

Letermovir = PPx
Targets CMV DNA terminase (pUL56)
Limited toxicity.”

Aaron Goodman: CMV drugs!

Source: Aaron Goodman/X

Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.

Aaron Goodman cancer CDV-phos Cidofovir CMV DNA terminase CMV drugs DNA electrolytes Fanconi syndrome Foscarnet Ganciclovir GCV-phos Letermovir nephrotoxicity OncoDaily Oncology pyrophosphate WBC

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage